Nazlı Gönç Selected Research

Neurofibromatosis-Noonan syndrome

3/2016

Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nazlı Gönç Research Topics

Disease

2	Precocious Puberty 01/2020 - 01/2011
2	Disorders of Sex Development (Intersexuality) 01/2018 - 09/2015
2	Hyperthyroidism 12/2015 - 05/2013
2	Hypothyroidism 05/2013 - 11/2012
1	Hypoglycemia (Reactive Hypoglycemia) 01/2022
1	Hyperinsulinism (Hyperinsulinemia) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Gynecomastia 01/2022
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2020
1	Brain Diseases (Brain Disorder) 11/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2018
1	Proteinuria 11/2018
1	Motor Partial Epilepsy 11/2018
1	Neurofibromatosis-Noonan syndrome 03/2016
1	Thyroid Diseases (Thyroid Disease) 12/2015
1	Penis agenesis 09/2015
1	Hypospadias 09/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2013
1	Atherosclerosis 09/2013
1	Goiter 05/2013
1	Thyroid Hormone Resistance Syndrome (Thyroid Hormone Resistance) 05/2013
1	Hypercalcemia (Milk Alkali Syndrome) 03/2012
1	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 03/2012
1	Seizures (Absence Seizure) 03/2012
1	Hypophosphatasia 03/2012
1	Glucose Intolerance 01/2009
1	Pediatric Obesity 01/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009
1	Insulin Resistance 01/2009
1	Obesity 01/2009

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2009
2	Insulin (Novolin)FDA Link 01/2022 - 01/2009
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2020 - 01/2011
2	Growth Hormone (Somatotropin)IBA 03/2016 - 11/2012
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 05/2013 - 11/2012
1	Congenital disorder of glycosylation type 1AIBA 01/2022
1	Diazoxide (Hyperstat)FDA Link 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	FatsIBA 01/2022
1	Glucagon (Glukagon)FDA Link 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	AndrogensIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Leuprolide (Lupron)FDA LinkGeneric 01/2020
1	coenzyme Q10 (CoQ10)IBA 11/2018
1	Hormones (Hormone)IBA 01/2018
1	EnzymesIBA 09/2015
1	HomocysteineIBA 09/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2013
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 09/2013
1	Thyroid HormonesIBA 05/2013
1	Thyroid Hormone Receptors beta (TR beta)IBA 05/2013
1	Antithyroid Agents (Antithyroid Drugs)IBA 05/2013
1	ProlactinIBA 11/2012
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 03/2012
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 03/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2012
1	Alkaline PhosphataseIBA 03/2012
1	GonadotropinsIBA 01/2011
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	LeptinIBA 01/2009
1	LipidsIBA 01/2009
1	AdiponectinIBA 01/2009
1	AdipokinesIBA 01/2009

Therapy/Procedure

1	Duration of Therapy 01/2022
1	Therapeutics 01/2020
1	Transplantation 12/2015
1	Hematopoietic Stem Cell Transplantation 12/2015